DigestRedComo funciona
Digest/ Comunicado

The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2025

Compatibilidad
Ahorrar(0)
Compartir
The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2025
Materiales adjuntos (1)

20094_164011_2026_oneinfo.pdf

Descargar kit de prensa ->
Detalles de contacto

Comunicados relacionados

05/08/2025
Finanzas
Ahorro/Finanzas personales
Fondos de inversión
Industria
Growing revenue Adjusted EBITDA was €21.6 million, +35%, and margins for 16.8%
Fuente
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Editor
1INFO
Descubre afinidades
0
06/11/2025
Finanzas
Ahorro/Finanzas personales
Fondos de inversión
Industria
Fine Foods confirms growth trajectory: revenue +7%, Adjusted EBITDA was €30.5 million (+30.2%) and Adjusted EBITDA Margin 16.1%
Fuente
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Editor
1INFO
Descubre afinidades
0
13/03/2025
Finanzas
Ahorro/Finanzas personales
Fondos de inversión
Industria
The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. today reviewed and approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2024.
Fuente
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Editor
1INFO
Descubre afinidades
0